215 related articles for article (PubMed ID: 25787305)
1. Potassium 2-(1-hydroxypentyl)-benzoate inhibits ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathways.
Yang H; Xu S; Li J; Wang L; Wang X
Naunyn Schmiedebergs Arch Pharmacol; 2015 Sep; 388(9):983-90. PubMed ID: 25787305
[TBL] [Abstract][Full Text] [Related]
2. The naphthoquinone plumbagin suppresses ADP-induced rat platelet aggregation through P2Y1-PLC signaling pathway.
Zhang Q; Liao X; Wu F
Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):573-578. PubMed ID: 28650323
[TBL] [Abstract][Full Text] [Related]
3. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia.
Zhang Y; Wang L; Li J; Wang XL
J Pharmacol Exp Ther; 2006 Jun; 317(3):973-9. PubMed ID: 16527903
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
5. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
6. Potassium 2-(1-hydroxypentyl)-benzoate attenuated hydrogen peroxide-induced apoptosis in neuroblastoma SK-N-SH cells.
Hu Y; Peng Y; Long Y; Xu S; Feng N; Wang L; Wang X
Eur J Pharmacol; 2012 Apr; 680(1-3):49-54. PubMed ID: 22329894
[TBL] [Abstract][Full Text] [Related]
7. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.
Fox SC; Behan MW; Heptinstall S
Cell Calcium; 2004 Jan; 35(1):39-46. PubMed ID: 14670370
[TBL] [Abstract][Full Text] [Related]
9. Potassium 2-(1-hydroxypentyl)-benzoate improves learning and memory deficits in chronic cerebral hypoperfused rats.
Zhao W; Xu S; Peng Y; Ji X; Cao D; Li J; Liu B; Shi Q; Wang L; Wang X
Neurosci Lett; 2013 Apr; 541():155-60. PubMed ID: 23416317
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the aggregation responses of camel platelets.
Al Ghumlas AK; Gader AG
Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
[TBL] [Abstract][Full Text] [Related]
11. Role of intracellular signaling events in ADP-induced platelet aggregation.
Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
[TBL] [Abstract][Full Text] [Related]
13. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
14. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
15. Conversion and pharmacokinetics profiles of a novel pro-drug of 3-n-butylphthalide, potassium 2-(1-hydroxypentyl)-benzoate, in rats and dogs.
Li J; Xu SF; Peng Y; Feng N; Wang L; Wang XL
Acta Pharmacol Sin; 2018 Feb; 39(2):275-285. PubMed ID: 28905934
[TBL] [Abstract][Full Text] [Related]
16. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
Khan N; Farooq AD; Sadek B
Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
[TBL] [Abstract][Full Text] [Related]
17. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
[TBL] [Abstract][Full Text] [Related]
18. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
19. Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.
Li PP; Wang WP; Liu ZH; Xu SF; Lu WW; Wang L; Wang XL
Acta Pharmacol Sin; 2014 Jul; 35(7):869-78. PubMed ID: 24858312
[TBL] [Abstract][Full Text] [Related]
20. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
